Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EW0P | ISIN: US00808Y4061 | Ticker-Symbol: EJU0
Frankfurt
10.05.24
09:24 Uhr
1,060 Euro
-0,070
-6,19 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
AETHLON MEDICAL INC Chart 1 Jahr
5-Tage-Chart
AETHLON MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,0101,09010.05.
1,0401,08010.05.

Aktuelle News zur AETHLON MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrWhat's Going On With Medical Therapeutic Firm Aethlon Medical On Friday?1
FrAethlon jumps on positive results from in vitro binding study of Hemopurifier device2
FrAethlon Medical Stock Surges In Pre-market On Positive Hemopurifier Trial Results-
FrAETHLON MEDICAL INC - 8-K, Current Report4
FrAethlon Medical, Inc.: Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles From Cancer Patient Plasma19Translational Study Provides Pre-Clinical Evidence to Support The Design of a Phase 1 Study of the Hemopurifier In Cancer Patients With Solid Tumors Treated With Anti-PD-1 Antibodies Aethlon Medical...
► Artikel lesen
25.04.AETHLON MEDICAL INC - S-1/A, General form for registration of securities2
25.04.AETHLON MEDICAL INC - 8-K, Current Report2
05.04.AETHLON MEDICAL INC - S-1/A, General form for registration of securities1
22.03.Aethlon Medical files to sell common stock, warrants1
22.03.AETHLON MEDICAL INC - S-1, General form for registration of securities1
21.02.Aethlon Inks Materials Transfer Deal For Santersus' NucleoCapture And HemoNucleoCapture Devices2
21.02.Aethlon Medical, Inc.: Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices256Aethlon Medical Will Perform Pre-Clinical Studies to Explore Potential Synergies With its First-in-Class Hemopurifier® Blood Filtration System SAN DIEGO, Feb. 21, 2024 /PRNewswire/ -- Aethlon Medical...
► Artikel lesen
15.02.Earnings call: Aethlon Medical Q3 FY2024 results and trials update1
15.02.Aethlon Medical Inc reports results for the quarter ended in December - Earnings Summary1
14.02.AETHLON MEDICAL INC - 10-Q, Quarterly Report1
14.02.Aethlon Medical GAAP EPS of -$1.37 in-line1
14.02.Recap: Aethlon Medical Q3 Earnings1
14.02.Aethlon Medical, Inc.: Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update156Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO, Feb. 14, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to...
► Artikel lesen
13.02.Aethlon Medical Q3 2024 Earnings Preview1
13.02.Aethlon Medical Inc expected to post a loss of $1.23 a share - Earnings Preview1
Seite:  Weiter >>
32 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1